Atrial Fibrillation after RSV Vaccination Among Older Adults

Morgan Birabaharan; Scott T Johns; David C Kaelber; Thomas C S Martin; Sanjay R Mehta

doi:10.1093/cid/ciae649

Atrial Fibrillation after RSV Vaccination Among Older Adults

Clin Infect Dis. 2024 Dec 26:ciae649. doi: 10.1093/cid/ciae649. Online ahead of print.

Authors

Morgan Birabaharan¹, Scott T Johns², David C Kaelber³, Thomas C S Martin^{1

2}, Sanjay R Mehta^{1

2}

Affiliations

¹ Division of Infectious Diseases and Global Public Health, University of California, San Diego, La Jolla, California, USA.
² San Diego Veterans Affairs Medical Center, San Diego, California, USA.
³ Departments of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.

PMID: 39724318
DOI: 10.1093/cid/ciae649

Abstract

RSV vaccine clinical trials reported higher frequencies of atrial fibrillation in intervention groups compared to control. In this large, population-based, propensity-matched study, we found RSV vaccine was not associated with increased risk of new-onset or recurrent atrial fibrillation within 1-42 days compared to influenza or Tdap vaccines.

© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For commercial re-use, please contact [email protected] for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact [email protected].